Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety and Tolerability Study of SR57667B in Outpatients With Early Parkinson's Disease

NCT00228150 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00228150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00228150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety and Tolerability Study of SR57667B in Outpatients With Early Parkinson's Disease
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2003
Completion date
April 30, 2006
Enrollment
564 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease